<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01218815</url>
  </required_header>
  <id_info>
    <org_study_id>3.0/2010</org_study_id>
    <nct_id>NCT01218815</nct_id>
  </id_info>
  <brief_title>Complete Infarct Related Artery Revascularization</brief_title>
  <acronym>CORAMI</acronym>
  <official_title>Complete Infarct Related Artery Revascularization in Acute Myocardial Infarction Patients - CORAMI Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundacja Ośrodek Badań Medycznych</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundacja Ośrodek Badań Medycznych</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      CORAMI trial is a prospective, international, multicenter randomized study which will be
      performed in experienced invasive facility centres with 24/7 PCI (percutaneous coronary
      intervention) duty and patient enrollment will continue for 18 months (October 2010 - March
      2012).The aim of the study is to compare strategy of complete vs target lesion-only primary
      PCI in IRA (infarct related artery) in STEMI (ST elevation myocardial infarction) patients.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Due to very low enrollment rate the study was terminated.
  </why_stopped>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ST resolution in ECG (electrocardiogram) and MBG (myocardial blush grade)</measure>
    <time_frame>in-hospital directly after PCI</time_frame>
    <description>This is a combined end-point of ST - segment resolution &gt;70% assessed directly after PCI
+ MBG 3 assessed directly after PCI (assessments by ECG and QCA Corelab).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical major ischemic events</measure>
    <time_frame>12-months</time_frame>
    <description>Death at 12-month clinical follow-up
Stent thrombosis at 12-month follow-up according to ARC definition
reMI at 12 months
urgent TVR at 12 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events and complications during hospital stay</measure>
    <time_frame>during patient index hospitalization (up to 7 days)</time_frame>
    <description>Immediate in-hospital angiographic complications (at least one or more of the following: distal embolisation, no-reflow, slow-flow, acute coronary artery occlusion,artery perforation, tamponade, dissection type B and above)
urgent in-hospital Target Vessel Revascularization (PCI and/or CABG - coronary artery bypass graft)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1</enrollment>
  <condition>Myocardial Infarction</condition>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Culprit lesion IRA Revascularization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Primary PCI of culprit lesion in IRA with drug eluting stent (DES) and PCI of the other critical lesion in IRA with another DES</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Complete IRA revascularization</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Primary PCI of culprit lesion in IRA with DES stent</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>IRA stenting in culprit lesion only</intervention_name>
    <description>stenting</description>
    <arm_group_label>Culprit lesion IRA Revascularization</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>IRA stenting</intervention_name>
    <description>Complete IRA revascularization</description>
    <arm_group_label>Complete IRA revascularization</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of STEMI (according to ESC 2007 definition)

          -  Chest pain onset &lt;12 hours

          -  signed informed consent

          -  Presence of two critical lesions requiring PCI in IRA (LAD - left anterior descending,
             Cx - circumflex, RCA - right coronary artery)

          -  Target/culprit lesion which requires immediate stenting (&gt;50 - 100%) and second
             critical lesion (70-90%) with TIMI 3 flow after PCI of the 1st target/culprit lesion

          -  Over 18 years of age

          -  IRA diameter ≥ 2.5 mm

        Exclusion Criteria:

          -  Terminal illness with life expectancy less &lt;1 year or active cancer disease -
             Pregnancy or possibility of pregnancy

          -  Second critical lesion in IRA &gt;90% or occlusion

          -  Contraindications to PCI or/and stent implantation

          -  Contraindications to DES stent implantation

          -  Lesion diameters unsuitable for intended stent platform

          -  Active bleeding or coagulopathy

          -  Patient in cardiogenic shock (&lt;90mmHg SBP and/or requiring IABP - intraaortic balloon
             pump - or vasopressors) - Killip 4 class

          -  Patient has Left Bundle Branch Block (LBBB) or pacemaker rhythm

          -  No future patient cooperation expected

          -  Patient is participating in another clinical study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dariusz Dudek, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Interventional Cardiology, Jagiellonian University Medical College in Krakow, Poland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>I Katedra i Klinika Kardiologii, Warszawski Uniwersytet Medyczny</name>
      <address>
        <city>Warszawa</city>
        <state>Banacha 1a</state>
        <zip>02-097</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Podkarpackie Centrum Interwencji Sercowo -Naczyniowych NZOZ</name>
      <address>
        <city>Sanok</city>
        <state>Podkarpackie</state>
        <zip>38-500</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pracownia Hemodynamiki Szpital im. E. Szczeklika</name>
      <address>
        <city>Tarnow</city>
        <state>Szpitalna 13</state>
        <zip>33-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centrum Kardiologii Inwazyjnej GVM Carint</name>
      <address>
        <city>Ostrowiec Swietokrzyski</city>
        <state>Szymanowskiego 11</state>
        <zip>27-400</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centrum Kardiologii Inwazyjnej GVM Carint</name>
      <address>
        <city>Oswiecim</city>
        <state>Wysokie Brzegi 4</state>
        <zip>32-600</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Interventional Cardiology, Jagiellonian University Medical College</name>
      <address>
        <city>Krakow</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krakowskie centrum Kardiologii Inwazyjnej, Elektroterapii i Angiologii, Carint Scanmed Sp. z o.o.</name>
      <address>
        <city>Kraków</city>
        <zip>30-693</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SP ZZOZ Powiatowy Szpital Specjalistyczny</name>
      <address>
        <city>Stalowa Wola</city>
        <zip>37-450</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instytut Kardiologii im. Prymasa Tysiąclecia Stefana Kardynała Wyszyńskiego</name>
      <address>
        <city>Warszawa</city>
        <zip>04-628</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Departament of Cardiology, University Hospital, Ljubljana</name>
      <address>
        <city>Ljubljana</city>
        <zip>1000</zip>
        <country>Slovenia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
    <country>Slovenia</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 1, 2010</study_first_submitted>
  <study_first_submitted_qc>October 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 11, 2010</study_first_posted>
  <last_update_submitted>March 5, 2015</last_update_submitted>
  <last_update_submitted_qc>March 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

